| |
Concentration
| | |
Quantity
| |
---|
|
Baseline
|
After haemorrhage
|
Resuscitated
| |
Resuscitated
| |
---|
HS (μg/ml)
| | | |
HS (μg/kg)
|
FFP
|
22 ± 20
|
85 ± 37
|
53 ± 21
|
*#
|
2879 ± 1075
|
†
|
ALB
|
11 ± 6
|
88 ± 46
|
59 ± 33
|
*#
|
3318 ± 1814
|
†
|
RA
|
15 ± 10
|
79 ± 37
|
92 ± 28
|
†
|
3731 ± 777
|
†
|
SHAM
|
20 ± 13
|
37 ± 19
|
37 ± 25
| |
1683 ± 1396
| |
Syndecan-1 (ng/ml)
| | | |
Syndecan-1 (ng/kg)
|
FFP
|
15.3 ± 3.1
|
20.6 ± 6.1
|
19.5 ± 4.2
| |
1061 ± 219
|
†
|
ALB
|
15.1 ± 4.8
|
16.5 ± 4.0
|
18.0 ± 5.0
| |
970 ± 240
|
†
|
RA
|
16.1 ± 3.3
|
17.5 ± 4.5
|
22.6 ± 6.3
|
*†
|
906 ± 253
|
†
|
SHAM
|
16.3 ± 2.0
|
16.3 ± 3.1
|
14.5 ± 1.9
| |
605 ± 145
| |
- Values are means ± SD. The change in concentration after resuscitation compared to after haemorrhage within groups was evaluated with paired t test corrected for multiple analyses with the Bonferroni correction (*P < 0.05). Differences in between groups after resuscitation was analysed with one-way repeated measurement ANOVA followed by post hoc testing using the Newman-Keuls correction
-
FFP fresh frozen plasma, ALB albumin, RA Ringer’s acetate
-
#Significant difference compared to the Ringer’s acetate group
-
†Significant difference compared to SHAM, P < 0.05